Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pharmacological Reviews|June 1, 2004
Neuromedin U and its receptors: structure, function, and physiological rolesPaul J Brighton, Philip G Szekeres, Gary B Willars
Journal of Cellular Biochemistry|September 25, 2008
Elk-1, CREB, and MKP-1 regulate Egr-1 expression in gonadotropin-releasing hormone stimulated gonadotrophsSabine I Mayer, Gary B Willars, Eisuke Nishida, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2006
C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cellsNawal M Al-Rasheed, Gary B Willars, Nigel J Brunskill
European Journal of Pharmacology|May 7, 2008
Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11Aikaterini Karakoula, Stephen C Tovey, Paul J Brighton, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 9, 2008
Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissuePaul J Brighton, Alan Wise, Narinder B Dass, et al.
Immunology|March 25, 2010
Characterization of the migration of lung and blood T cells in response CXCL12 in a three-dimensional matrixCaroline E Day, Cristina Guillen, Gary B Willars, et al.
Molecular Pharmacology|August 28, 2004
Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interactionPaul J Brighton, Philip G Szekeres, Alan Wise, et al.
Molecular Pharmacology|May 5, 2018
Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 ReceptorKhaled Alhosaini, Omar Bahattab, Heider Qassam, et al.
Frontiers in Pharmacology|April 2, 2020
Hazards of Using <i>Masking Protocols</i> When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 ReceptorsHaider Abbas, Preeti Borde, Gary B Willars, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2011
PERK activation at low glucose concentration is mediated by SERCA pump inhibition and confers preemptive cytoprotection to pancreatic β-cellsClaire E Moore, Omotola Omikorede, Edith Gomez, et al.
Pageof 4